TuHURA Biosciences (HURA) Acquisitions (2020)
TuHURA Biosciences' (HURA) quarterly Acquisitions came in at $969000.0 in Q3 2020.
TuHURA Biosciences (HURA) Acquisitions (2020) Analysis & Trends
TuHURA Biosciences' Acquisitions history runs 1 years deep, the most recent figure standing at $969000.0 for Q3 2020.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $969000.0 in Q3 2020; TTM through Jun 2021 was $969000.0, a N/A change from a year earlier, with the FY2021 full-year figure at $969000.0, changed N/A from the prior year.
- Acquisitions held at $969000.0 in Q3 2020 per HURA's latest filing.
- Across five years, Acquisitions topped out at $969000.0 in Q3 2020 and bottomed at $969000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 969,000.00 |